Page last updated: 2024-10-27

flecainide and Cirrhosis

flecainide has been researched along with Cirrhosis in 5 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research Excerpts

ExcerptRelevanceReference
"Fibrosis was triggered by transforming growth factor β (TGF-β) pathway activation."1.46Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease. ( Baró, I; Cerpa, CO; Charpentier, F; Colledge, WH; Derangeon, M; Girardeau, A; Grace, AA; Huang, CLH; Jagu, B; Montnach, J; Patin, J; Toumaniantz, G, 2017)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Hesselkilde, EZ1
Carstensen, H1
Flethøj, M1
Fenner, M1
Kruse, DD1
Sattler, SM1
Tfelt-Hansen, J1
Pehrson, S1
Braunstein, TH1
Carlson, J1
Platonov, PG1
Jespersen, T1
Buhl, R1
Bai, J1
Lo, A1
Gladding, PA1
Stiles, MK1
Fedorov, VV1
Zhao, J1
Derangeon, M1
Montnach, J1
Cerpa, CO1
Jagu, B1
Patin, J1
Toumaniantz, G1
Girardeau, A1
Huang, CLH1
Colledge, WH1
Grace, AA1
Baró, I1
Charpentier, F1
Blana, A1
Kaese, S1
Fortmüller, L1
Laakmann, S1
Damke, D1
van Bragt, K1
Eckstein, J1
Piccini, I1
Kirchhefer, U1
Nattel, S1
Breithardt, G1
Carmeliet, P1
Carmeliet, E1
Schotten, U1
Verheule, S1
Kirchhof, P1
Fabritz, L1
Blakeman, BP1
Wilber, D1

Other Studies

5 other studies available for flecainide and Cirrhosis

ArticleYear
Longitudinal study of electrical, functional and structural remodelling in an equine model of atrial fibrillation.
    BMC cardiovascular disorders, 2019, 10-21, Volume: 19, Issue:1

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function, Left; Atri

2019
In silico investigation of the mechanisms underlying atrial fibrillation due to impaired Pitx2.
    PLoS computational biology, 2020, Volume: 16, Issue:2

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Remodeling; Calcium;

2020
Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease.
    Cardiovascular research, 2017, Apr-01, Volume: 113, Issue:5

    Topics: Age Factors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Cardiomyopathies; Co

2017
Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
    Heart rhythm, 2010, Volume: 7, Issue:12

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Doppler;

2010
Surgical ablation for idiopathic ventricular tachycardia.
    The Annals of thoracic surgery, 1990, Volume: 49, Issue:2

    Topics: Adult; Bundle-Branch Block; Cryosurgery; Fibrosis; Flecainide; Humans; Hypertrophy; Male; Papillary

1990